Notably, many glycolytic enzymes are reported present in the serum of breast cancer patients, including aldolase A (ALDOA), ENO1, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 76. This evidence concerns the gene ENO1 and breast cancer.